WHAT IT IS TRYING TO CHANGE
What the project is doing
United Therapeutics / Thymmune THY-100 thymus-cell programme is being developed as part of the wider effort to prevent, delay or repair age-related decline.
What this could do for you
If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.
What has to happen next
The next checkpoint is a reproducible result strong enough to justify human testing.
What could stop it
Results in cells or animals often fail in people, and the route to a safe human treatment can take many years.